Nimbus Therapeutics Funding: $600M Raised, Series B

Nimbus Therapeutics is based in Boston, MA. It has raised $600M in total funding. Latest round: Series B. Backed by Atlas Venture, SR One, Lilly Ventures.

Nimbus Therapeutics funding overview

Nimbus Therapeutics is based in Boston, MA. Nimbus Therapeutics has raised $600M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B. Investors on record include Atlas Venture, SR One, Lilly Ventures, Pfizer Venture Investments, Lightstone Ventures, Schrödinger and 1 others. 7 distinct backers are named across the disclosed rounds.

Nimbus Therapeutics at a glance

Total raised
$600M
Latest round
Series B
Headquarters
Boston, MA
Notable investors
Atlas Venture, SR One, Lilly Ventures, Pfizer Venture Investments, Lightstone Ventures, Schrödinger, Bill Gates

Frequently asked about Nimbus Therapeutics funding

How much has Nimbus Therapeutics raised?
Nimbus Therapeutics has raised $600M in total disclosed funding across the rounds on record.
Who has invested in Nimbus Therapeutics?
Atlas Venture, SR One, Lilly Ventures, Pfizer Venture Investments, Lightstone Ventures, Schrödinger are named among the investors backing Nimbus Therapeutics.
What was the latest Nimbus Therapeutics funding round?
The most recent disclosed round is a Series B.
Where is Nimbus Therapeutics based?
Nimbus Therapeutics is based in Boston, MA.

Nimbus Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.

Companies related to Nimbus Therapeutics (34)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026